PLoS ONE (Jan 2013)

R31C GNRH1 mutation and congenital hypogonadotropic hypogonadism.

  • Luigi Maione,
  • Frederique Albarel,
  • Philippe Bouchard,
  • Megan Gallant,
  • Colleen A Flanagan,
  • Regis Bobe,
  • Joelle Cohen-Tannoudji,
  • Rosario Pivonello,
  • Annamaria Colao,
  • Thierry Brue,
  • Robert P Millar,
  • Marc Lombes,
  • Jacques Young,
  • Anne Guiochon-Mantel,
  • Jerome Bouligand

DOI
https://doi.org/10.1371/journal.pone.0069616
Journal volume & issue
Vol. 8, no. 7
p. e69616

Abstract

Read online

Normosmic congenital hypogonadotropic hypogonadism (nCHH) is a rare reproductive disease leading to lack of puberty and infertility. Loss-of-function mutations of GNRH1 gene are a very rare cause of autosomal recessive nCHH. R31C GNRH1 is the only missense mutation that affects the conserved GnRH decapeptide sequence. This mutation was identified in a CpG islet in nine nCHH subjects from four unrelated families, giving evidence for a putative "hot spot". Interestingly, all the nCHH patients carry this mutation in heterozygosis that strikingly contrasts with the recessive inheritance associated with frame shift and non-sense mutations. Therefore, after exclusion of a second genetic event, a comprehensive functional characterization of the mutant R31C GnRH was undertaken. Using different cellular models, we clearly demonstrate a dramatic reduction of the mutant decapeptide capacity to bind GnRH-receptor, to activate MAPK pathway and to trigger inositol phosphate accumulation and intracellular calcium mobilization. In addition it is less able than wild type to induce lh-beta transcription and LH secretion in gonadotrope cells. Finally, the absence of a negative dominance in vitro offers a unique opportunity to discuss the complex in vivo patho-physiology of this form of nCHH.